Press release from Companies: Curasight announces new date of the Annual General Meeting and an updated financial calendar 2022

Press release from Companies: Annual Report for the fiscal year 2021

Reports: Year-end report October - December 2021

Press release from Companies: Curasight expands its strategy and strengthen its position as a theranostic company

Press release from Companies: Curasight expands its strategy and strengthen its position as a theranostic company

Press release from Companies: Curasight strengthens its strategic position with the acquisition of TRT Innovations ApS

Press release from Companies: Curasight strengthens its strategic position with the acquisition of TRT Innovations ApS

Press release from Companies: Phase II study of uPAR-PET in neuroendocrine tumor patients demonstrates strong prognostic value and supports potential future use of uPAR-targeted radionuclide therapy

Press release from Companies: Curasight presents at the SEB Nordic Healthcare Seminar 2022 and at Kapital Partner

Press release from Companies: Curasight attends the J.P. Morgan Healthcare Conference and presents at HC Andersen Capital

Press release from Companies: Curasight attends the J.P. Morgan Healthcare Conference and presents at HC Andersen Capital

Press release from Companies: Hanne Damgaard Jensen joins Curasight A/S as Chief Development Officer (CDO)